Achiko AG – Investor Briefing
07 juil. 2022 15h22 HE
|
Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 26, 2022
20 juin 2022 20h24 HE
|
Achiko AG
ZURICH, Switzerland, June 20, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 10, 2022
06 juin 2022 07h40 HE
|
Achiko AG
ZURICH, Switzerland, June 06, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko Secures $1.3 Million Financing with Strategic Investors Buranto AG and Negma Group
25 mai 2022 07h30 HE
|
Achiko AG
Buranto AG Provided a USD$260,000 (CHF 250,000) Loan Facility and Existing Strategic Investor Negma Group Provided a USD$1.04 Million (CHF 1.0 Million) Loan FacilityDerek Brandt, Co-owner of Buranto...
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by May 31, 2022
29 avr. 2022 07h30 HE
|
Achiko AG
ZURICH, Switzerland, April 29, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Achiko’s Position on Omicron Variant
02 déc. 2021 07h30 HE
|
Achiko AG
The chemical mode of action of AptameX, Achiko's rapid Covid-19 test, strongly suggests that Omicron can be detected as reliably as any other Covid-19 variant known to dateAchiko’s highly effective,...
Achiko Initiates Development of Dengue Diagnostic Test
05 nov. 2021 07h30 HE
|
Achiko AG
Achiko to develop dengue fever diagnostic test by applying its DNA aptamer technology platform. This is another promising application of the technology that Achiko is already successfully using to...
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
27 oct. 2021 07h30 HE
|
Achiko AG
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by...
Achiko Launches Covid-19 Testing Pilot Program in Indonesia
07 oct. 2021 07h30 HE
|
Achiko AG
Launch of pilot program in Indonesia for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service, Teman Sehat (“Health Buddy”).Purpose...